Kingsview Wealth Management LLC Boosts Stake in Zoetis Inc. (NYSE:ZTS)

Kingsview Wealth Management LLC raised its holdings in Zoetis Inc. (NYSE:ZTS) by 1.0% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 9,986 shares of the company’s stock after acquiring an additional 97 shares during the period. Kingsview Wealth Management LLC’s holdings in Zoetis were worth $1,627,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of the business. Darwin Wealth Management LLC bought a new stake in Zoetis during the third quarter valued at approximately $31,000. First Personal Financial Services purchased a new stake in shares of Zoetis during the 3rd quarter valued at $33,000. Capital Performance Advisors LLP bought a new stake in shares of Zoetis during the 3rd quarter worth $33,000. Dunhill Financial LLC grew its position in Zoetis by 80.6% in the third quarter. Dunhill Financial LLC now owns 168 shares of the company’s stock worth $33,000 after acquiring an additional 75 shares in the last quarter. Finally, Fortitude Family Office LLC increased its stake in Zoetis by 1,387.5% in the third quarter. Fortitude Family Office LLC now owns 238 shares of the company’s stock valued at $46,000 after acquiring an additional 222 shares during the last quarter. Institutional investors own 92.80% of the company’s stock.

Zoetis Price Performance

ZTS stock opened at $171.71 on Tuesday. The stock has a market capitalization of $77.47 billion, a price-to-earnings ratio of 32.28, a PEG ratio of 2.77 and a beta of 0.90. The firm’s 50-day moving average price is $169.26 and its two-hundred day moving average price is $179.21. The company has a current ratio of 3.69, a quick ratio of 2.27 and a debt-to-equity ratio of 1.26. Zoetis Inc. has a 12-month low of $144.80 and a 12-month high of $200.53.

Zoetis Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 3rd. Investors of record on Monday, April 21st will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, April 21st. This represents a $2.00 dividend on an annualized basis and a yield of 1.16%. Zoetis’s dividend payout ratio is presently 37.59%.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on ZTS shares. Leerink Partnrs raised Zoetis to a “strong-buy” rating in a research note on Monday, December 2nd. Piper Sandler dropped their target price on Zoetis from $210.00 to $200.00 and set an “overweight” rating for the company in a research report on Monday. Stifel Nicolaus reduced their price target on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a research report on Tuesday, January 7th. Leerink Partners initiated coverage on shares of Zoetis in a report on Monday, December 2nd. They issued an “outperform” rating and a $215.00 price objective for the company. Finally, UBS Group started coverage on shares of Zoetis in a report on Monday, December 9th. They set a “neutral” rating and a $196.00 target price on the stock. One analyst has rated the stock with a hold rating, ten have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $214.00.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.